Bristol-Myers Squibb Company News Headlines

BMY 
$49.46
*  
0.35
 negative 
0.71%
Get BMY Alerts
*Delayed - data as of Apr. 17, 2014 
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

AstraZeneca: FDA Approves Myalept For Leptin Deficiency Treatment
2/25/2014 2:17:00 PM - Dow Jones Business News

Bristol-Myers Gets FDA Breakthrough Therapy Designation For Hepatitis Drug
2/25/2014 6:46:00 AM - RTT News

BIOL Has Reason To Smile, CBMG Walks The Talk, CLSN Warms Up, REGN Catches Eyes
2/25/2014 1:24:00 AM - RTT News

Pfizer Gets Good News For Pneumonia, Bone-Thinner Drugs
2/24/2014 6:12:00 PM - Investor's Business Daily

Bristol-Myers To Present At Citi Health Care Conference; Webcast At 2:40 PM ET
2/24/2014 1:40:00 PM - RTT News

Encouraging Data on Bristol-Myers/Pfizer's Eliquis - Analyst Blog
2/24/2014 12:50:01 PM - Zacks.com

FDA Gives BMY Hep-C Drug 'Breakthrough' Status
2/24/2014 12:20:00 PM - Fox Business

Bristol-Myers Hepatitis C Treatment Receives FDA Breakthrough Therapy Status
2/24/2014 10:33:00 AM - Dow Jones Business News

Bristol-Myers Squibb Gets FDA Breakthrough Therapy Designation For Hepatitis C
2/24/2014 8:49:00 AM - RTT News

Bristol-Myers Squibb To Participate In Citi Global Health Care At 2:40 PM ET
2/24/2014 8:00:00 AM - RTT News

Exelixis Q4 Loss In Line with Expectations - Analyst Blog
2/21/2014 1:04:01 PM - Zacks.com

Agenus: Acquisition Of 4-Antibody Is A Transformational Move
2/20/2014 2:28:51 PM - SeekingAlpha

Agenus: Acquisition Of 4-Antibody Is A Transformational Move
2/20/2014 2:01:00 PM - Seeking Alpha

Bristol-Myers: 5 Different Insiders Have Sold Shares This Month
2/20/2014 8:26:00 AM - Seeking Alpha

Galena Biopharma: The Oncologist's Perspective On A Life Saving Therapy
2/19/2014 6:53:00 PM - Seeking Alpha

Stock Market News for February 19, 2014 - Market News
2/19/2014 11:06:01 AM - Zacks.com

Update: Week Ending February 15, 2014
2/16/2014 6:15:00 AM - Seeking Alpha

FDA Panel Negative on The Medicines Co.'s Cangrelor - Analyst Blog
2/13/2014 6:10:01 PM - Zacks.com

Cadence Soars on Deal with Mallinckrodt - Analyst Blog
2/12/2014 1:25:01 PM - Zacks.com

Frantic Pace In Cancer Immunotherapy: Merck Vs. Bristol-Myers
2/12/2014 3:13:00 AM - Seeking Alpha

FDA Seeks Clinical Trial Data From AstraZeneca On Diabetes Drug Saxagliptin
2/11/2014 11:13:00 PM - RTT News

The Medicines Co. Slips Ahead of FDA Panel - Analyst Blog
2/11/2014 6:10:01 PM - Zacks.com

FDA to Review Data for AstraZeneca Diabetes Drug
2/11/2014 2:55:00 PM - Dow Jones Business News

FDA to Review Clinical Trial Data for AstraZeneca Diabetes Drug
2/11/2014 2:41:00 PM - Dow Jones Business News

Bristol-Myers Squibb Moves Up In Analyst Rankings, Passing Prudential Financial
2/11/2014 12:49:15 PM - BNK Invest